The medical needs and develop drug molecules to meet the market requirements, researchers develop activated or functionalized PEGs or antibody to perform the conjugation reactions to modify the API. After downstream processing, purification and formulation, the final API may then unfold the desired clinical effect. A prolonged pharmacological activity allows to reduce the frequency of drug administration and thus to improve the patient's quality of life.